Mediterranean Journal of Hematology and Infectious Diseases (Jun 2023)
Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation
Abstract
Background: Immune and inflammatory processes have known contributions to the pathogenesis of myelodysplastic syndromes (MDS). The use of inflammatory markers, minimally used in current practice, is examined.
Keywords